1. Home
  2. CNTB vs AMTX Comparison

CNTB vs AMTX Comparison

Compare CNTB & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Connect Biopharma Holdings Limited

CNTB

Connect Biopharma Holdings Limited

N/A

Current Price

$0.62

Market Cap

140.4M

Sector

Health Care

ML Signal

N/A

Logo Aemetis Inc. (DE)

AMTX

Aemetis Inc. (DE)

N/A

Current Price

$0.95

Market Cap

134.2M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CNTB
AMTX
Founded
2012
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
140.4M
134.2M
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
CNTB
AMTX
Price
$0.62
$0.95
Analyst Decision
Strong Buy
Buy
Analyst Count
7
4
Target Price
$5.71
★ $12.39
AVG Volume (30 Days)
599.6K
★ 1.7M
Earning Date
11-16-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 32.98
EPS
N/A
★ N/A
Revenue
$64,000.00
★ $77,194,000.00
Revenue This Year
$7,473.67
$31.48
Revenue Next Year
$240.46
$32.40
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 174.60
52 Week Low
$0.55
$1.01
52 Week High
$3.82
$3.80

Technical Indicators

Market Signals
Indicator
CNTB
AMTX
Relative Strength Index (RSI) 36.76 31.85
Support Level N/A N/A
Resistance Level $2.62 $1.85
Average True Range (ATR) 0.07 0.16
MACD 0.01 -0.04
Stochastic Oscillator 33.75 0.43

Price Performance

Historical Comparison
CNTB
AMTX

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. The operations include California Ethanol, California Dairy Renewable Natural Gas and India Biodiesel. It operates in the reportable geographic segments of North America and India.

Share on Social Networks: